Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

NCT06065371 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancer

Interventions

DRUG: Capecitabine
DRUG: Sacituzumab govetican

Sponsor

Henry Ford Health System

Collaborators

[object Object]